INMUNE BIO INC. Increase (Decrease) in Accounts Payable, Related Parties
INMUNE BIO INC. (INMB) reported Increase (Decrease) in Accounts Payable, Related Parties of $159.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2026-08-06
- INMUNE BIO INC. increase (decrease) in accounts payable, related parties for the quarter ending 2025-06-30 was $81.00K, a 2.41% decline year-over-year.
- INMUNE BIO INC. increase (decrease) in accounts payable, related parties for the quarter ending 2025-03-31 was $78.00K, a 271.43% increase year-over-year.
- INMUNE BIO INC. increase (decrease) in accounts payable, related parties for the quarter ending 2024-12-31 was -$30.00K.
- INMUNE BIO INC. increase (decrease) in accounts payable, related parties for the quarter ending 2024-09-30 was -$84.00K.
- INMUNE BIO INC. increase (decrease) in accounts payable, related parties for fiscal 2024 was -$10.00K, a 138.46% decline from fiscal 2023.
- INMUNE BIO INC. increase (decrease) in accounts payable, related parties for fiscal 2023 was $26.00K.
- INMUNE BIO INC. increase (decrease) in accounts payable, related parties for fiscal 2022 was -$71.00K, a 254.35% decline from fiscal 2021.
- INMUNE BIO INC. increase (decrease) in accounts payable, related parties for fiscal 2021 was $46.00K.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 3 month as first filed | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month as first filed | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month as first filed | Increase (Decrease) in Accounts Payable, Related Parties 12 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | $81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $159.00K 10-Q · filed 2026-08-06 | $129.00K derived: sum of 3 quarters · filed 2026-08-06 | $45.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $78.00K 10-Q · filed 2026-05-07 | $48.00K derived: sum of 2 quarters · filed 2026-05-07 | -$36.00K derived: sum of 3 quarters · filed 2026-05-07 | $47.00K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$114.00K derived: sum of 2 quarters · filed 2026-03-30 | -$31.00K derived: sum of 3 quarters · filed 2026-03-30 | -$10.00K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$1.00K derived: sum of 2 quarters · filed 2025-10-30 | $20.00K 10-Q · filed 2025-10-30 | -$24.00K derived: sum of 4 quarters · filed 2025-10-30 | ||||
| 2024-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $104.00K 10-Q · filed 2025-08-07 | $60.00K derived: sum of 3 quarters · filed 2025-08-07 | |||||
| 2024-03-31 | $21.00K 10-Q · filed 2025-05-08 | -$23.00K derived: sum of 2 quarters · filed 2025-05-08 | ||||||
| 2023-12-31 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $26.00K 10-K · filed 2025-03-27 | ||||||
| 2023-09-30 | $70.00K 10-Q · filed 2024-10-31 | |||||||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | -$71.00K 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$1.00K derived: sum of 2 quarters · filed 2023-11-01 | -$72.00K 10-Q · filed 2023-11-01 | -$2.00K derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$71.00K 10-Q · filed 2023-08-07 | -$1.00K derived: sum of 3 quarters · filed 2023-08-07 | $0.00 derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | -$71.00K 10-Q · filed 2023-05-03 | -$1.00K derived: sum of 2 quarters · filed 2023-05-03 | $0.00 derived: sum of 3 quarters · filed 2023-05-03 | -$1.00K derived: sum of 4 quarters · filed 2023-05-03 | ||||
| 2021-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $71.00K derived: sum of 2 quarters · filed 2023-03-02 | $70.00K derived: sum of 3 quarters · filed 2023-03-02 | $46.00K 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | -$24.00K 10-Q · filed 2022-11-02 | $1.00K derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$25.00K 10-Q · filed 2022-08-03 | $0.00 derived: sum of 3 quarters · filed 2022-08-03 | -$214.00K derived: sum of 4 quarters · filed 2022-08-03 | ||||
| 2021-03-31 | -$24.00K 10-Q · filed 2022-05-05 | $1.00K derived: sum of 2 quarters · filed 2022-05-05 | -$213.00K derived: sum of 3 quarters · filed 2022-05-05 | -$93.00K derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$189.00K derived: sum of 2 quarters · filed 2022-03-03 | -$69.00K derived: sum of 3 quarters · filed 2022-03-03 | -$40.00K 10-K · filed 2022-03-03 | -$40.68K 10-K · filed 2021-03-04 | |||
| 2020-09-30 | -$214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$94.00K derived: sum of 2 quarters · filed 2021-11-03 | -$65.00K 10-Q · filed 2021-11-03 | -$65.21K 10-Q · filed 2020-11-05 | $62.99K derived: sum of 4 quarters · filed 2021-11-03 | |||
| 2020-06-30 | $120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $149.00K 10-Q · filed 2021-08-04 | $149.22K 10-Q · filed 2020-08-05 | $276.99K derived: sum of 3 quarters · filed 2021-08-04 | $369.21K derived: sum of 4 quarters · filed 2021-08-04 | |||
| 2020-03-31 | $29.00K 10-Q · filed 2021-05-05 | $28.54K 10-Q · filed 2020-05-14 | $156.99K derived: sum of 2 quarters · filed 2021-05-05 | $249.21K derived: sum of 3 quarters · filed 2021-05-05 | $217.49K derived: sum of 4 quarters · filed 2021-05-05 | |||
| 2019-12-31 | $127.99K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $220.21K derived: sum of 2 quarters · filed 2021-03-04 | $188.49K derived: sum of 3 quarters · filed 2021-03-04 | $19.56K 10-K · filed 2021-03-04 | ||||
| 2019-09-30 | $92.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $60.50K derived: sum of 2 quarters · filed 2020-11-05 | -$108.43K 10-Q · filed 2020-11-05 | $140.30K derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$31.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$200.65K 10-Q · filed 2020-08-05 | $60.87K 10-Q · filed 2019-08-09 | $48.08K derived: sum of 3 quarters · filed 2020-08-05 | $23.35K derived: sum of 4 quarters · filed 2020-08-05 | |||
| 2019-03-31 | -$168.93K 10-Q · filed 2020-05-14 | $200.00 10-Q · filed 2019-05-15 | $79.81K derived: sum of 2 quarters · filed 2020-05-14 | $55.07K derived: sum of 3 quarters · filed 2020-05-14 | $91.70K derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | $248.74K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $224.00K derived: sum of 2 quarters · filed 2020-03-11 | $260.63K derived: sum of 3 quarters · filed 2020-03-11 | $87.08K 10-K · filed 2020-03-11 | -$174.44K 10-K · filed 2019-03-29 | |||
| 2018-09-30 | -$24.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $11.90K derived: sum of 2 quarters · filed 2019-11-08 | -$161.65K 10-Q · filed 2019-11-08 | |||||
| 2018-06-30 | $36.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$136.92K 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | -$173.55K 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | $170.36K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |